Pittenger & Anderson Inc’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$28.8K	Hold	115	–	–	﹤0.01%	347
2025 Q4	$31.6K	Hold	115	–	–	﹤0.01%	333
2025 Q3	$30.2K	Hold	115	–	–	﹤0.01%	323
2025 Q2	$25.2K	Hold	115	–	–	﹤0.01%	319
2025 Q1	$25.7K	Sell	115 -374	-76%	-$103K	﹤0.01%	313
2024 Q4	$160K	Buy	489 +80	+20%	+$25.2K	0.01%	231
2024 Q3	$123K	Sell	409 -2,547	-86%	-$780K	﹤0.01%	263
2024 Q2	$974K	Buy	2,956 +98	+3%	+$34.6K	0.04%	161
2024 Q1	$1.13M	Buy	2,858 +1,159	+68%	+$429K	0.05%	149
2023 Q4	$598K	Buy	1,699 +315	+23%	+$111K	0.03%	173
2023 Q3	$519K	Buy	1,384 +716	+107%	+$277K	0.03%	164
2023 Q2	$255K	Buy	668 +166	+33%	+$59.3K	0.01%	191
2023 Q1	$174K	Buy	502 +167	+50%	+$48.8K	0.01%	210
2022 Q4	$78.8K	Sell	335 -8,611	-96%	-$2.04M	﹤0.01%	250
2022 Q3	$2.2M	Buy	8,946 +550	+7%	+$168K	0.13%	127
2022 Q2	$2.54M	Buy	8,396 +365	+5%	+$119K	0.15%	126
2022 Q1	$3.3M	Buy	8,031 +190	+2%	+$74.4K	0.16%	118
2021 Q4	$3.68M	Buy	7,841 +385	+5%	+$166K	0.17%	116
2021 Q3	$3.17M	Buy	7,456 +141	+2%	+$59.4K	0.16%	120
2021 Q2	$2.63M	Buy	7,315 +195	+3%	+$64.4K	0.13%	131
2021 Q1	$2.01M	Buy	+7,120	New	+$2.04M	0.11%	137